Hyaluronan expression in gastric cancer cells is associated with local and nodal spread and reduced survival rate.
about
Regulation of hyaluronidase activity by alternative mRNA splicingAntisense inhibition of hyaluronan synthase-2 in human osteosarcoma cells inhibits hyaluronan retention and tumorigenicityRole of hyaluronan in pancreatic cancer biology and therapy: Once again in the spotlightLipid Raft-Mediated Regulation of Hyaluronan-CD44 Interactions in Inflammation and CancerOrchestrating the Tumor Microenvironment to Improve Survival for Patients With Pancreatic Cancer: Normalization, Not DestructionExpression of CD44 and its variant isoform v3 has no prognostic value in gastric cancer.Is hyaluronan deposition in the stroma of pancreatic ductal adenocarcinoma of prognostic significance?Improving the distribution of Doxil® in the tumor matrix by depletion of tumor hyaluronanPrognostic impact of hyaluronan and its regulators in pancreatic ductal adenocarcinoma.Inhibition of oesophageal squamous cell carcinoma progression by in vivo targeting of hyaluronan synthesis.Inhibition of hyaluronan retention by 4-methylumbelliferone suppresses osteosarcoma cells in vitro and lung metastasis in vivo.Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival.Perturbation of hyaluronan interactions by soluble CD44 inhibits growth of murine mammary carcinoma cells in ascites.Hyaluronic acid-based nanocarriers for intracellular targeting: interfacial interactions with proteins in cancer.Desmoplasia in Primary Tumors and Metastatic Lesions of Pancreatic Cancer.Antitumor effects of the hyaluronan inhibitor 4-methylumbelliferone on pancreatic cancerExtracellular matrix in bone marrow can mediate drug resistance in myeloma.The role of hyaluronic acid in hemopoietic stem cell biology.Synthesis of N-acetyl Glucosamine Analogs as Inhibitors for Hyaluronan Biosynthesis.Microanalysis of stomach cancer glycosaminoglycans.Aberrant splice variants of HAS1 (Hyaluronan Synthase 1) multimerize with and modulate normally spliced HAS1 protein: a potential mechanism promoting human cancerInvasive cancers are not necessarily from preformed in situ tumours - an alternative way of carcinogenesis from misplaced stem cells4-Methylumbelliferone Suppresses Hyaluronan Synthesis and Tumor Progression in SCID Mice Intra-abdominally Inoculated With Pancreatic Cancer Cells.Mechanotransduction in cancer.The Development of a Novel Therapeutic Strategy to Target Hyaluronan in the Extracellular Matrix of Pancreatic Ductal Adenocarcinoma.Therapeutic targeting of hyaluronan in the tumor stroma.Sugars in the microenvironment: the sticky problem of HA turnover in tumors.Opposing effects of high- and low-molecular weight hyaluronan on CXCL12-induced CXCR4 signaling depend on CD44Antitumor effects of 4-methylumbelliferone, a hyaluronan synthesis inhibitor, on malignant peripheral nerve sheath tumor.Hyaluronic acid in digestive cancers.Accumulation of small hyaluronan oligosaccharides in tumour interstitial fluid correlates with lymphatic invasion and lymph node metastasis.Targeting the Tumor Stroma: the Biology and Clinical Development of Pegylated Recombinant Human Hyaluronidase (PEGPH20).Hyaluronan oligosaccharides inhibit tumorigenicity of osteosarcoma cell lines MG-63 and LM-8 in vitro and in vivo via perturbation of hyaluronan-rich pericellular matrix of the cells.Identification of CD44 as a surface biomarker for drug resistance by surface proteome signature technology.Phase 1 trials of PEGylated recombinant human hyaluronidase PH20 in patients with advanced solid tumours.Hyaluronan expression in differentiated thyroid carcinoma.Differential effect of transforming growth factor beta (TGF-beta) on the genes encoding hyaluronan synthases and utilization of the p38 MAPK pathway in TGF-beta-induced hyaluronan synthase 1 activation.HALO-109-301: a Phase III trial of PEGPH20 (with gemcitabine and nab-paclitaxel) in hyaluronic acid-high stage IV pancreatic cancer.A Trickster in Disguise: Hyaluronan's Ambivalent Roles in the Matrix.The eukaryotic translation initiation factor eIF4E harnesses hyaluronan production to drive its malignant activity.
P2860
Q24300353-E41F9DD3-ECC7-458B-8DC3-A7CF479BFAFCQ24635382-C3A2EA30-47C1-4FC6-9ED6-0EAFEB4B087BQ26766075-002D46EE-FE6D-4508-B65A-818EDC882D20Q26782792-31582422-5570-4A27-A575-4925FF45C25EQ26801834-E470E59F-66D7-4F0F-B23B-4F726A1B575AQ31789296-E03ABA5B-2315-46B6-92AC-403F23F125C3Q33764696-52C72B58-1CAA-4B91-9089-60D46B40FBBDQ34145464-CBBDEFE0-AAEC-45B1-9BF9-608B6DFEA8CAQ34385867-F2ABC90D-E849-40C4-A27E-845F497BBB3CQ34809359-AA8EB035-C4E3-4790-8D83-2654C995A4A2Q35653938-A6102FCC-3BF1-49BC-9369-D77585F692F7Q35745456-C40B26C6-1FB6-422A-8991-671C761E5626Q35745534-0161786B-0092-4C2E-B420-3B272EEFFBC6Q35837359-B4836CA1-97BF-4573-ACB5-648CA1FB377FQ35920843-F87687FD-4342-40DD-A6A8-A712D43FF3F3Q36152259-E809AA5B-776F-4537-BBF8-E03C5021EEB0Q36194659-AD70ADD2-388F-4FFB-8819-86CC57A08C63Q36804635-35AA7707-0FBC-4DA6-8B18-37D692C49227Q36807807-72452BDB-420D-42FE-A3A9-5D45D5EF0EBDQ37161351-55B723D3-1B3D-48EE-80ED-9735362FF3ABQ37253985-11DC51E9-CA34-425C-AE33-FC429E9D824AQ37294719-13917B65-97E2-4731-9DB3-93DE862FA4D1Q37606733-6341C303-F217-4F26-B64B-50CA23C92527Q37716062-D076BE04-54F8-4BDA-9D49-D010CA2CBC6CQ37729238-7DC25C2D-EA7B-43A2-96E9-E7A26D57BBE0Q38161392-3E9A29F1-932A-42EA-9029-E7D06578A57BQ38260975-34312A73-D6D1-4955-9F97-E498B9D38F79Q38312173-9E1AF69D-CB9F-4C1E-B2DE-3D33F15EAE0FQ38740401-E272D9A6-0155-4838-A7A1-ADF34B10A245Q38930438-82C6BFBD-2E76-414F-8140-B977DB3B867FQ38983885-897EB86D-EADC-4203-93E9-B4614B910B76Q39356378-A69A36F4-804D-43AA-AA25-CEFA33982A11Q41843755-97A3B1F8-711D-41D8-A47A-2B8317278BE2Q41983563-D9E4CC1F-C0A4-478B-8100-D05545FEBB59Q43837471-ADE7007F-954B-4C16-9E5D-6678C01C46DEQ43856146-359F930C-B683-4C22-9DDD-D490BB26E369Q44693918-91BECD51-B8A5-48E0-9225-4EA29907DB9AQ46180368-AA9A0D0F-D4B5-4BBE-80FD-90592BB7D102Q46276542-D95C3A24-57CE-4F20-A091-FE0725B72006Q47151662-78352850-5449-4F8A-B0A0-6E5BD6C7868D
P2860
Hyaluronan expression in gastric cancer cells is associated with local and nodal spread and reduced survival rate.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Hyaluronan expression in gastr ...... ead and reduced survival rate.
@ast
Hyaluronan expression in gastr ...... ead and reduced survival rate.
@en
type
label
Hyaluronan expression in gastr ...... ead and reduced survival rate.
@ast
Hyaluronan expression in gastr ...... ead and reduced survival rate.
@en
prefLabel
Hyaluronan expression in gastr ...... ead and reduced survival rate.
@ast
Hyaluronan expression in gastr ...... ead and reduced survival rate.
@en
P2093
P2860
P356
P1476
Hyaluronan expression in gastr ...... ead and reduced survival rate.
@en
P2093
Eskelinen MJ
Lipponen PK
Parkkinen J
P2860
P2888
P304
P356
10.1038/SJ.BJC.6690180
P407
P577
1999-03-01T00:00:00Z
P5875
P6179
1029414045